The log (base 10) ratio ofPvalues for relative miRNA expression was plotted for each miRNA in descending order of formal name

The log (base 10) ratio ofPvalues for relative miRNA expression was plotted for each miRNA in descending order of formal name. synthetase expression, cell culture experiments were conducted. Glutamine synthetase was also evaluated in the gut tissues of patients. == Results == A subset of IBS patients (8/19, 42%) experienced increased intestinal membrane permeability and decreased glutamine synthetase expression compared to IBS patients with normal membrane permeability and to controls. Expression of miR-29a was increased in blood microvesicles, small bowel and colon tissues of IBS patients with increased intestinal membrane permeability. Increased intestinal permeability was modulated by miR-29a which has a complementary site in the 3′-UTR of the GLUL gene. == Conclusions == The results support the conclusion that GLUL regulates intestinal membrane permeability and miR-29a regulates both GLUL and intestinal membrane permeability. The data suggests that miR-29a effects on intestinal membrane permeability may be due to its regulation of GLUL. Targeting this signaling pathway could lead to a new therapeutic approach to the treatment of patients with IBS, especially because small molecules that mimic or inhibit miRNA-based mechanisms are readily available. Keywords:Irritable bowel syndrome (IBS), miRNA, miR-29a, blood microvesicles, glutamine synthetase gene (GLUL), glutamine synthetase, intestinal membrane permeability == INTRODUCTION == Irritable bowel syndrome (IBS) is one of the most frequent functional gastrointestinal disorders seen by physicians. It affects up to 20% of the United States population.1However, the pathophysiological mechanisms underlying abdominal pain and chronic symptoms in IBS are not well 3-Cyano-7-ethoxycoumarin understood.2,3Several studies have recently shown that patients with diarrhea-predominant IBS have increased intestinal membrane permeability.47Low-grade inflammation has also been reported in mucosal biopsies of some patients with increased intestinal membrane permeability.5Indeed, patients with both inflammatory and non-inflammatory GI conditions CD121A such as inflammatory bowel disease, irritable bowel syndrome, celiac sprue, and acute alcoholic gastroenteritis have increased gut permeability.710Aadorable symptoms in these disorders abdominal pain, diarrhea, urgency and bloating usually coincide with acute inflammation (as is seen in patients with IBS). Transient inflammation of the gut may cause sensitization of enteric neurons which persists long after resolution of the inflammation (post-infectious IBS)6. Several recent animal models have also been reported in which there is alteration of motility and/or sensory function following a transient inflammatory event.1113 Glutamine synthetase (GS) catalyzes the conversion of ammonia and glutamate to glutamine. It plays a major role in cell signaling, ammonia detoxification, inter-organ nitrogen flux, and acid-base homeostasis. Congenital glutamine deficiencies have been reported in children with glutamine synthetase gene (GLUL) mutations.14Because of the multiple functions and importance of glutamine synthetase in cellular metabolism, both catalytic activities and synthesis are highly regulated. Previously, it has been well established that deficiencies in glutamine may lead to increased membrane permeability and supplementation with glutamine can restore intestinal membrane permeability.1517Thus, conditions in which decreased levels of intestinal glutamine synthetase are present may lead to low levels of available 3-Cyano-7-ethoxycoumarin glutamine and increased intestinal membrane permeability. Blood microvesicles are circular membrane fragments that are shed from your cell surface, and act as cell-to-cell and cell-to-organ communicators. Virtually all cells are able to release small-size vesicles (microvesicles) derived from the plasma membrane (microparticles) or from multivesicular endocytic compartments (exosomes). Several recent studies have also shown that shedding of membrane-derived microvesicles accompanies cell activation. 1825Activation of microvesicles may serve as a physiological vehicle to deliver diverse molecules to cells, and ultimately to functional organs. Changes in molecular 3-Cyano-7-ethoxycoumarin signature and quantity of microvesicles may be used to characterize certain disease processes and allow the development of new diagnostic strategies.26,27 MicroRNAs (miRNAs) are a class of 2123 nucleotide long non-coding RNA molecules. They are cleaved from 70- to 100-nucleotide hairpin pre-miRNA precursors. Single-stranded miRNAs bind through partial sequence complementarity to the 3′-UTR of target mRNAs and cause a block of translation as well as some degree of mRNA degradation. miRNAs are involved in the regulation of gene expression in critical biological processes, including development, differentiation, apoptosis and proliferation, through imperfect pairing with target mRNAs of protein coding genes.28,29The miRNA (miR)-29 family (29a, 29b, 29c) has significant complementarities to the 3`-UTRs of DNA methyltransferase 3A and -3B (de novo methyltransferases), two key enzymes involved in DNA methylation.30Although a role for aberrant miRNA expression in gastrointestinal 3-Cyano-7-ethoxycoumarin disorders has been postulated, the pathophysiologic role and relevance of the expression 3-Cyano-7-ethoxycoumarin of specific miRNAs in patients with IBS has not been reported. The objective of our study was to evaluate the role of aberrantly expressed miRNA and its direct target genes.